Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M. C., Florencia, E. F., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,202 · see citing works

Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

Zheng, Y., Danilenko, D., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 2,034 · see citing works

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N. M., Guzzo, C. A., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,870 · see citing works

A systematic review of worldwide epidemiology of psoriasis

Michałek, I. M., Loring, B., & John, S. M. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13854 · Cited by 1,158 · see citing works

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

Leonardi, C. L., Matheson, R. T., Zachariae, C. O. C., Cameron, G. S., LI, L. C., Edson‐Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 933 · see citing works

Macrophage Myeloperoxidase Regulation by Granulocyte Macrophage Colony-Stimulating Factor in Human Atherosclerosis and Implications in Acute Coronary Syndromes

Sugiyama, S., Okada, Y., Sukhova, G. K., Virmani, R., Heinecke, J. W., & Libby, P. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64036-9 · Cited by 699 · see citing works

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses

Zaba, L. C., Cardinale, I. R., Gilleaudeau, P., Sullivan-Whalen, M. M., Suárez‐Fariñas, M., Fuentes‐Duculan, J., Novitskaya, I., Khatcherian, A., Bluth, M. J., Lowes, M. A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071094 · Cited by 676 · see citing works

New member of the winged-helix protein family disrupted in mouse and rat nude mutations

Nehls, M. C., Pfeifer, D., Schorpp, M., Hedrich, H. J., & Boehm, T. L. J. (1994) · Nature · doi:10.1038/372103a0 · Cited by 635 · see citing works

Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis

Harper, E. G., Guo, C., Rizzo, H. L., Lillis, J. V., Kurtz, S. E., Skorcheva, I., Purdy, D. E., Fitch, E., Iordanov, M. S., & Blauvelt, A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.65 · Cited by 511 · see citing works

Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization

Schultz, J., & Kaminker, K. (1962) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(62)90321-1 · Cited by 403 · see citing works

Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytes

Valdimarsson, H., Bake, B. S., Jónsdótdr, I., & Fry, L. (1986) · Immunology Today · doi:10.1016/0167-5699(86)90005-8 · Cited by 325 · see citing works

Neutrophils in Psoriasis

Chiang, C.-C., Cheng, W.-J., Kořínek, M., Lin, C.-Y., & Hwang, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02376 · Cited by 294 · see citing works

Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis

Herster, F., Bittner, Z., Archer, N. K., Dickhöfer, S., Eisel, D., Eigenbrod, T., Knorpp, T., Schneiderhan‐Marra, N., Loeffler, M. W., Kalbacher, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13756-4 · Cited by 268 · see citing works

Myeloperoxidase: A new player in autoimmunity

Strzępa, A., Pritchard, K. A., & Dittel, B. N. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.05.002 · Cited by 236 · see citing works

Neutrophil Extracellular Traps Promote Inflammatory Responses in Psoriasis via Activating Epidermal TLR4/IL-36R Crosstalk

Shao, S., Fang, H., Dang, E., Xue, K., Zhang, J., Li, B., Qiao, H., Cao, T., Zhuang, Y., Shen, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00746 · Cited by 220 · see citing works

Oxidative Stress as an Important Contributor to the Pathogenesis of Psoriasis

Pleńkowska, J., Gabig‐Cimińska, M., & Mozolewski, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176206 · Cited by 207 · see citing works

Role of Oxidative Stress in Various Stages of Psoriasis

Kadam, D. P., Suryakar, A. N., Ankush, R. D., Kadam, C. Y., & Deshpande, K. H. (2010) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0043-9 · Cited by 202 · see citing works

Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis

Swindell, W. R., Michaels, K. A., Sutter, A. J., Diaconu, D., Fritz, Y., Xing, X., Sarkar, M. K., Liang, Y., Tsoi, L. C., Gudjonsson, J. E., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0415-3 · Cited by 177 · see citing works

The global state of psoriasis disease epidemiology: a workshop report

Griffiths, C. E. M., van der Walt, J. M., Ashcroft, D. M., Flohr, C., Naldi, L., Nijsten, T. E. C., & Augustin, M. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15610 · Cited by 172 · see citing works

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles

Swanson, N. A., Abramovits, W., Berman, B., Kulp, J., Rigel, D. S., & Levy, S. F. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.07.004 · Cited by 160 · see citing works

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles

Hanke, C. W., Beer, K. R., Stockfleth, E., Wu, J. K., Rosen, T., & Levy, S. F. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.06.020 · Cited by 155 · see citing works

Role of neutrophils in induction of acute inflammation in T‐cell‐mediated immune dermatosis, psoriasis: A neutrophil‐associated inflammation‐boosting loop

Terui, T., Ozawa, M., & Tagami, H. (2000) · Experimental Dermatology · doi:10.1034/j.1600-0625.2000.009001001.x · Cited by 150 · see citing works

Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis.

Bata‐Csörgõ, Z., Hammerberg, C., Voorhees, J. J., & Cooper, K. D. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.4.1271 · Cited by 128 · see citing works

Inhibition of myeloperoxidase oxidant production by N-acetyl lysyltyrosylcysteine amide reduces brain damage in a murine model of stroke

Yu, G., Liang, Y. S., Huang, Z., Jones, D. W., Pritchard, K. A., & Zhang, H. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0583-x · Cited by 103 · see citing works

Patient Measurement of Psoriasis Disease Severity with a Structured Instrument

Fleischer, A. B., Rapp, S. R., Reboussin, D. M., Vanarthos, J. C., & Feldman, S. R. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12384205 · Cited by 94 · see citing works

Macrophage Activation Includes High Intracellular Myeloperoxidase Activity

Rodrigues, M. R., Rodriguez, D., Russo, M., & Čampa, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6724 · Cited by 93 · see citing works

Immune evasion by a staphylococcal inhibitor of myeloperoxidase

de Jong, N. W. M., Ramyar, K. X., Guerra, F. E., Nijland, R., Fèvre, C., Voyich, J. M., McCarthy, A. J., Garcia, B. L., van Kessel, K. P. M., van Strijp, J. A. G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707032114 · Cited by 89 · see citing works

Functional Characterization of IL-17F as a Selective Neutrophil Attractant in Psoriasis

Watanabe, H., Kawaguchi, M., 藤島, 沙., Ogura, M., Matsukura, S., Takeuchi, H. T., Ohba, M., Sueki, H., Kokubu, F., Hizawa, N., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.294 · Cited by 84 · see citing works

The neutrophil: one cell on many missions or many cells with different agendas?

Christoffersson, G., & Phillipson, M. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2780-z · Cited by 83 · see citing works

Myeloperoxidase targets oxidative host attacks to Salmonella and prevents collateral tissue damage

Schürmann, N., Forrer, P., Casse, O., Li, J., Felmy, B., Burgener-Gasser, A.-V., Ehrenfeuchter, N., Hardt, W., Recher, M., Hess, C., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.268 · Cited by 82 · see citing works

Murine models of psoriasis and their usefulness for drug discovery

Chuang, S.-Y., Lin, C.-H., Sung, C. T., & Fang, J. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1463214 · Cited by 79 · see citing works

Biologic Therapies in the Treatment of Psoriasis: A Comprehensive Evidence-Based Basic Science and Clinical Review and a Practical Guide to Tuberculosis Monitoring

Sivamani, R. K., Goodarzi, H., Garcia, M. S., Raychaudhuri, S. P., Wehrli, L. N., Ono, Y., & Maverakis, E. M. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8301-7 · Cited by 77 · see citing works

Endogenous Myeloperoxidase Is a Mediator of Joint Inflammation and Damage in Experimental Arthritis

Odobasic, D., Yang, Y. H., Muljadi, R. C. M., O’Sullivan, K. M., Kao, W., Smith, M., Morand, E. F., & Holdsworth, S. R. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38299 · Cited by 76 · see citing works

Inhibition of myeloperoxidase at the peak of experimental autoimmune encephalomyelitis restores blood–brain barrier integrity and ameliorates disease severity

Zhang, H., Ray, A., Miller, N. M., Hartwig, D., Pritchard, K. A., & Dittel, B. N. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13426 · Cited by 76 · see citing works

Myeloperoxidase Deficiency Inhibits Cognitive Decline in the 5XFAD Mouse Model of Alzheimer’s Disease

Volkman, R., Ben‐Zur, T., Kahana, A., Garty, B. Z., & Offen, D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00990 · Cited by 72 · see citing works

Comparative Tolerability of Systemic Treatments for Plaque-Type Psoriasis

McClure, S. L., Valentine, J., & Gordon, K. B. (2002) · Drug Safety · doi:10.2165/00002018-200225130-00003 · Cited by 71 · see citing works

Induction of Fatal Inflammation in LDL Receptor and ApoA-I Double-Knockout Mice Fed Dietary Fat and Cholesterol

Zabalawi, M., Bhat, S., Loughlin, T., Thomas, M. J., Alexander, E. T., Cline, M., Bullock, B. C., Willingham, M. C., & Sorci‐Thomas, M. G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63480-3 · Cited by 65 · see citing works

Response of keratinocytes from normal and psoriatic epidermis to interferon‐γ differs in the expression of zinc‐α 2 ‐glycoprotein and cathepsin D

Chen, S., Arany, I., Apisarnthanarax, N., Rajaraman, S., Tyring, S. K., Horikoshi, T., Brysk, H., & Brysk, M. M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.3.565 · Cited by 62 · see citing works

The Topical Treatment of Psoriasis

van de Kerkhof, P. C. M., & Vissers, W. H. P. M. (2003) · Skin Pharmacology and Physiology · doi:10.1159/000069029 · Cited by 61 · see citing works

Myeloperoxidase Selectively Binds and Selectively Kills Microbes

Allen, R. C., & Stephens, J. T. (2010) · Infection and Immunity · doi:10.1128/iai.00910-09 · Cited by 59 · see citing works

Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects

Garzorz‐Stark, N., Lauffer, F., Krause, L., Thomas, J., Atenhan, A., Franz, R., Roenneberg, S., Boehner, A., Jargosch, M., Batra, R., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.045 · Cited by 57 · see citing works

[44] Human neutrophil degranulation

Wright, D. G. (1988) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(88)62102-1 · Cited by 55 · see citing works

N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor

Zhang, H., Jing, X., Shi, Y., Xu, H., Du, J., Guan, T., Weihrauch, D., Jones, D. W., Wang, W., Gourlay, D. M., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m038273 · Cited by 52 · see citing works

Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice

Zhang, H., Xu, H., Weihrauch, D., Jones, D. W., Jing, X., Shi, Y., Gourlay, D. M., Oldham, K. T., Hillery, C. A., & Pritchard, K. A. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m038281 · Cited by 51 · see citing works

The Effects of Topical Treatment with Steroids or Dithranol on Epidermal T Lymphocytes and Dendritic Cells in Psoriasis

Baker, B. S., SWAIN, A. F., Griffiths, C. E. M., LEONARD, J. N., Fry, L., & Valdimarsson, H. (1985) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1985.tb01905.x · Cited by 43 · see citing works

Inflammation and skin cholesterol in LDLr−/−, apoA-I−/− mice: link between cholesterol homeostasis and self-tolerance?

Zabalawi, M., Bharadwaj, M. S., Horton, H., Cline, M., Willingham, M. C., Thomas, M. J., & Sorci‐Thomas, M. G. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600370-jlr200 · Cited by 43 · see citing works

A Paired, Double-Blind, Randomized Comparison of a Moisturizing Durable Barrier Cream to 10% Glycerine Cream in the Prophylactic Management of Postmastectomy Irradiation Skin Care: Trans Tasman Radiation Oncology Group (TROG) 04.01

Graham, P., Plant, N. A., Graham, J. L., Browne, L. H., Borg, M. F., Capp, A., Delaney, G. P., Harvey, J., Kenny, L., Francis, M. B., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.12.009 · Cited by 40 · see citing works

Binding of myeloperoxidase to bacteria: effect on hydroxyl radical formation and susceptibility to oxidant-mediated killing

Britigan, B. E. (1996) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(96)00014-1 · Cited by 36 · see citing works

The economic burden of psoriasis with high comorbidity among privately insured patients in the United States

Pilon, D., Teeple, A., Zhdanava, M., Ladouceur, M., Cheung, H. C., Muser, E., & Lefèbvre, P. (2018) · Journal of Medical Economics · doi:10.1080/13696998.2018.1557201 · Cited by 34 · see citing works

Neutrophil-Derived Myeloperoxidase Facilitates Both the Induction and Elicitation Phases of Contact Hypersensitivity

Strzepa, A., Gurski, C. J., Dittel, L. J., Szczepanik, M., Pritchard, K. A., & Dittel, B. N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.608871 · Cited by 26 · see citing works

In Vivo Role of Myeloperoxidase for the Host Defense

Aratani, Y., Kura, F., Watanabe, H., Akagawa, H., Takano, Y., Suzuki, K. T., Dinauer, M. C., Maeda, N., & Koyama, H. (2004) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2004.s15 · Cited by 24 · see citing works

Reduction of Inter-Rater and Intra-Rater Variability in Psoriasis Area and Severity Index Assessment by Photographic Training

Youn, S. W., Choi, C. W., Kim, B. R., & Chae, J. B. (2015) · Annals of Dermatology · doi:10.5021/ad.2015.27.5.557 · Cited by 23 · see citing works

The C57BL/6 nude, beige mouse: A model of combined T cell and NK effector cell immunodeficiency

Pflumio, F., Fonteneau, P., Gavériaux‐Ruff, C., Cammisuli, S., & Loor, F. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90189-5 · Cited by 22 · see citing works

Cyclosporin in psoriasis: continuous monotherapy versus intermittent long-term therapy.

Ozawa, A., Sugai, J. B. D. C., Ohkido, M., Ohtsuki, M., Nakagawa, H., Kitahara, H., Tamaki, K., Urabe, K., Nakayama, J., Horikoshi, T., et al. (1999) · PubMed · Cited by 19 · see citing works

[35] Osmotic delivery systems for research

Fara, J. W. (1985) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(85)12037-9 · Cited by 17 · see citing works

Topical Treatment of Psoriasis

Kamili, Q. U. A., & Menter, A. (2009) · Current problems in dermatology · doi:10.1159/000232303 · Cited by 16 · see citing works

Myeloperoxidase-associated Tyrosine Nitration after Intratracheal Administration of Lipopolysaccharide in Rats

Hataishi, R., Kobayashi, H., Takahashi, Y., Hirano, S., Zapol, W. M., & Jones, R. C. (2002) · Anesthesiology · doi:10.1097/00000542-200210000-00021 · Cited by 14 · see citing works

Imaging of Neutrophils and Neutrophil Extracellular Traps (NETs) with Intravital (In Vivo) Microscopy

Cichoń, I., Santocki, M., Ortmann, W., & Kołaczkowska, E. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0154-9_26 · Cited by 13 · see citing works

National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference

Afifi, L., Shankle, L., Armstrong, A. W., Boas, M., Bridges, A., Chiguil, V., Doris, F., Duffin, K. C., Fielding, E. J., Fleischmann, R., et al. (2017) · Journal of Psoriasis and Psoriatic Arthritis · doi:10.1177/247553031700200307 · Cited by 12 · see citing works

Continuous Central Nervous System Infusion with Alzet Osmotic Pumps

Hagg, T. (1994) · Methods in neurosciences · doi:10.1016/b978-0-12-185291-7.50018-7 · Cited by 10 · see citing works

Aldara-Induced Psoriasis-Like Skin Inflammation: Isolation and Characterization of Cutaneous Dendritic Cells and Innate Lymphocytes

Wohn, C., Pantelyushin, S., Ober-Blöbaum, J. L., & Clausen, B. E. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1212-4_16 · Cited by 9 · see citing works

Three parameters affecting interlitter variations

Woods, V. E., & Epstein, H. T. (1979) · Developmental Psychobiology · doi:10.1002/dev.420120406 · Cited by 4 · see citing works

Psoriasis

Sterry, W. 1.-2., Sabat, R. 1., & Philipp, S. (2014) · Wiley eBooks · doi:10.1002/9781118661796 · Cited by 3 · see citing works

Treatment Satisfaction and Health-related Quality of Life among Individuals with Psoriasis: National Psoriasis Foundation Survey Findings

Horn, E. J., Fox, K. M., Patel, V. D., Kimball, A. B., Gordon, K. B., & Lebwohl, M. (2008) · Psoriasis Forum · doi:10.1177/247553030814a00205 · Cited by 2 · see citing works

Clinical testing of new drugs for lesional skin diseases such as psoriasis A new delivery system

Farber, E. M., Wilkinson, D. I., & Trozak, D. J. (1995) · Skin Research and Technology · doi:10.1111/j.1600-0846.1995.tb00013.x · Cited by 1 · see citing works

Alefacept selectively reduces memory-effector (CD45RO+) T cells and improves clinical outcomes in psoriasis and psoriatic arthritis

Dinant, H. J., van Kuijk, A. W. R., Goedkoop, A. Y., Kraan, M. C., de Rie, M. A., Dijkmans, B. A. C., Vaishnaw, A. K., Krueger, G. G., & Tak, P. P. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(02)81916-9 · Cited by 1 · see citing works

Plaque psoriasis

Sterry, W. (2014) · doi:10.1002/9781118661796.ch6 · Cited by 1 · see citing works

Hypochlorous Acid: From Innate Immune Factor and Environmental Toxicant to Chemopreventive Agent Targeting Solar UV-Induced Skin Cancer

Snell, J. A., Jandova, J., & Wondrak, G. T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.887220 · Cited by 37 · see citing works

Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis

Mai, Y., Ouyang, Y., Yu, M., Qin, Y., Girardi, M., Saltzman, W. M., Cocco, E., Zhao, C., Liu, Y., Jia, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.006 · Cited by 35 · see citing works

Temporal Dynamics of Oxidative Stress and Inflammation in Bronchopulmonary Dysplasia

Teng, M., Wu, T.-J., Jing, X., Day, B. W., Pritchard, K. A., Naylor, S., & Teng, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810145 · Cited by 34 · see citing works

Unraveling Mitochondrial Reactive Oxygen Species Involvement in Psoriasis: The Promise of Antioxidant Therapies

Jamil, H. A., & Karim, N. A. (2024) · Antioxidants · doi:10.3390/antiox13101222 · Cited by 32 · see citing works

Role of Myeloperoxidase, Oxidative Stress, and Inflammation in Bronchopulmonary Dysplasia

Wu, T.-J., Jing, X., Teng, M., Pritchard, K. A., Day, B. W., Naylor, S., & Teng, R. (2024) · Antioxidants · doi:10.3390/antiox13080889 · Cited by 31 · see citing works

Tetrastigma hemsleyanum polysaccharides alleviate imiquimod-induced psoriasis-like skin lesions in mice by modulating the JAK/STAT3 signaling pathway

Lv, Y., Liu, Y., Mao, Z., Zhou, M., Zhu, B., Chen, Y., Ding, Z., Zhou, F., & Ye, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155917 · Cited by 30 · see citing works

Transcriptional inhibition of STAT1 functions in the nucleus alleviates Th1 and Th17 cell-mediated inflammatory diseases

Park, J., Son, M., Ho, C.-C., Lee, S.-H., Kim, Y., An, J., & Lee, S.-K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1054472 · Cited by 30 · see citing works

Myeloperoxidase as a Marker to Differentiate Mouse Monocyte/Macrophage Subsets

Gurski, C. J., & Dittel, B. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158246 · Cited by 22 · see citing works

Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway

Bharatha, M., Nandana, M. B., Praveen, R., Nayaka, S., Velmurugan, D., Vishwanath, B. S., & Rajaiah, R. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111679 · Cited by 17 · see citing works

How Cells Die in Psoriasis?

Chen, C.-H., Wu, N., & Tsai, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083747 · Cited by 16 · see citing works

Dermal adipogenesis protects against neutrophilic skin inflammation during psoriasis pathogenesis

Zhang, L., Zhang, L.-J., Zhang, L.-J., Xia, T., Xia, R., Xia, T., Zhang, W., Zhang, W., Zhang, W., Wu, R., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01296-5 · Cited by 15 · see citing works

Synergistic effects of LCN2 and TWEAK on the progression of psoriasis

Ren, K., Peng, X., Duan, X., Feng, R., Cook, C., Lü, M., Li, M., Gu, H., Wang, X., Deng, G., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01292-9 · Cited by 14 · see citing works

NLRP3-inflammasome Related Genes as Emerging Biomarkers and Therapeutic Targets in Psoriasis

Shi, A., Shu, Y., Hu, K., Sudesh, S. M., & Tu, Y. (2025) · Inflammation · doi:10.1007/s10753-025-02271-y · Cited by 13 · see citing works

Low-Molecular-Weight Collagen Peptide Improves Skin Dehydration and Barrier Dysfunction in Human Dermal Fibrosis Cells and UVB-Exposed SKH-1 Hairless Mice

Choi, E., Joo, H., Kim, M., Kim, D.-U., Chung, H., & Kim, J. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136427 · Cited by 13 · see citing works

Harnessing Microneedles for Delivery and Preservation of Natural Killer Cell-Derived Extracellular Vesicles

Lim, S., Chen, S., Suzuki, I., Lambaren, K., Soleimani, A., Ho, N., Mousavi, M. P. S., & Chung, E. J. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00760 · Cited by 10 · see citing works

Modulation of Skin Inflammatory Responses by Aluminum Adjuvant

Liao, Y., Sun, L., Nie, M., Li, J., Huang, X., Heng, S., Zhang, W., Xia, T., Guo, Z., Zhao, Q., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020576 · Cited by 10 · see citing works

Gene expression analysis of oxidative stress-related genes in the apical, middle, and basal turns of the cochlea

Yang, Y., Chen, X., Tian, C., Fan, B., An, X., Liu, Z., Li, Q., Mi, W., Lin, Y. L., & Zha, D. (2024) · Gene Expression Patterns · doi:10.1016/j.gep.2024.119356 · Cited by 10 · see citing works

Butyrate receptor HCAR2/GPR109A controls imiquimod-induced psoriasis-like skin inflammation

Leko, L., Šimić, D., Martins, T. V., da Silva, G. V. L., Maillet, I., Savigny, F., Vuksan, L., Rodrigues, D. D. M., Bert, M. L., Offermanns, S., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf069 · Cited by 9 · see citing works

Foamed microemulsion nanodroplets loaded with chlorin e6 for epidermal-targeted treatment against psoriasis

Ma, X., Bian, Q., Xu, Y., Hu, J., Hu, W., Wang, R., Zhang, Y., Ye, Y., Sheng, X., Zhang, T., et al. (2024) · Nano Research · doi:10.1007/s12274-024-6916-7 · Cited by 7 · see citing works

Discovery of Novel N-Sulfonamide-tetrahydroquinolines as Potent Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists for the Treatment of Psoriasis

Lv, L., Chen, B., Gao, Y., Sun, N., Li, W., & Fu, W. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02318 · Cited by 5 · see citing works

Keratinocyte SR-B1 expression and targeting in cytokine-driven skin inflammation

Trujillo, J. M., Calvert, A. E., Rink, J. S., White, B. E. P., Sepulveda, F., Biyashev, D., Lu, K. Q., Lavker, R. M., Peng, H., & Thaxton, C. S. (2025) · Communications Medicine · doi:10.1038/s43856-025-00804-y · Cited by 3 · see citing works

Euphorbia humifusa Willd. extract alleviates imiquimod-induced psoriasis-like skin lesions in mice by modulating the IL-17 signaling pathway

Alimujiang, A., Wang, H., Chen, L., Kang, Y., Zhao, J., Wei, W., Huo, S., Xu, D., & Li, Z. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120030 · Cited by 2 · see citing works

The Therapeutic Potential of Extracellular Vesicles in Psoriasis Treatment: Mechanisms, Applications, and Prospects

Dayem, A. A., Song, M., Park, J., Jeong, K., Lim, K. M., Kim, S., Song, K., & Cho, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110297 · Cited by 2 · see citing works

Low-molecular-weight heparin sodium inhibits the MAPK pathway for psoriasis treatment in mice

Wang, J., He, C., Guo, Y., Zhong, Z., Shu, L., Fang, Z., & Zhang, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139372 · Cited by 2 · see citing works

Anti-Psoriatic Effects of J2H-1802, a Mycophenolate Mofetil and 5-Aminosalicylic Acid Hybrid, in an Imiquimod-Induced Psoriasis-like Mouse Model

Park, S.-H., Lee, J. H., Yoon, K.-N., Yang, G., Kim, J., Lee, J. Y., Choi, K., Jung, K., Lee, S., Son, W., et al. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18030380 · Cited by 1 · see citing works

Pathological Mechanism‐Inspired Biomimetic Nano‐Senotherapy for Reversing Experimental Atherosclerosis in ApoE −/− Mice

Tian, Y., Yang, Y., Li, Q., Hu, Y., Hu, Q., Ran, S., Zhou, S., Yang, X., Li, S., & Zhang, Q. (2026) · Advanced Science · doi:10.1002/advs.75850 · Cited by 1 · see citing works

Enhanced BEST2 expression in keratinocytes alleviates psoriatic inflammation

Ma, L., Wang, J., Li, D., & Wen, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115077

Human Dermal Fibroblast-derived Spheroids Demonstrate Efficacious Immune Modulation in a Psoriasis Mouse ModelPreprint

Fang, C., Embile, I. B., Boyer, C. J., Gebremeskel, S., Bazhanov, N., Jiang, B., Raghuram, S., Taruishi, M., O’Heeron, P., & Khoja, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.04.668478

Sulfotransferase SULT2B1 contributes to the epithelial–immune microenvironment homeostasis in imiquimod-induced psoriatic dermatitis

Morino, K., Akiyoshi, S., Matsubara, K., Sugiura, Y., Izumi, Y., Yotsumoto, S., Yamamura, K., Maeda, R., Takahashi, M., Nakata, K., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1632426

COMPARATIVE IN VITRO AND IN VIVO EVALUATIONS OF NIOSOMAL GEL VS. CONVENTIONAL GEL PREPARATIONS FOR THE TREATMENT OF PSORIASIS

Matlapudi, M. S., Areti, A. R., Jaiswal, Y., & Bantal, V. (2025) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.582

Cycloastragenol Ameliorates Psoriasis by Promoting Keratinocyte Autophagy via Modulating Subcellular Localization of ZKSCAN3

Xia, J., Zhang, D., Zhang, T., Wang, Q., & Liu, Y. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70210

Immunological liver-skin axis: a systemic Vγ4 + γδT17 cell response links psoriasis-like inflammation and MASLDPreprint

Fleissner, J., Rocca, Y., Freund, L., Ossner, T., Imdahl, F., Doucet-Ladevèze, R., Kurz, F., Geier, A., Goebeler, M., Gasteiger, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.22.695890

Sihe Tufuling formula alleviates imiquimod-induced psoriasis-like skin lesions in mice by modulating the HIF-1 signaling pathway

Kang, Y., Alimujiang, A., Zhou, F., Chen, L., Wang, H., Wei, W., Zhao, J., Zhu, Z., Sun, W., Xie, X., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158033

Luliconazole-loaded PLGA Polymeric Micelles for Enhanced Topical Treatment of Seborrheic Dermatitis: In-Vitro and In Vivo Study

Dbiky, H. I., Elezaby, R. S., Ibrahim, H. M., & Abdel-Mottaleb, M. M. A. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10555-5

Formulation and Evaluation of Mometasone Furoate–loaded Niosomal Topical Gel for Enhanced Psoriasis Treatment: In vitro Characterization and In vivo Therapeutic Potential

Matlapudi, M. S., Areti, A. R., Jaiswal, Y., & Bantal, V. S. (2026) · Nano LIFE · doi:10.1142/s1793984426500066

Keratinocyte-specific STAT3 knockout attenuates imiquimod-induced psoriasiform phenotype in mice

Li, L., Zhang, C., Chen, L., Yao, W., Hou, X., Zhengxiao, L., & Tian, F. (2026) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.26-0047

High Fat Diet‐Induced Obesity Alters Cutaneous Immune Cell Function, and These Changes Persist After Weight Loss

Kamada, W., Tanno, H., Takayashiki, R., Sato, Y., Ishi, S., Shoji, M., Sato, K., Aoyagi, T., & Kanno, E. (2026) · Journal of Immunology Research · doi:10.1155/jimr/3930910

Celecoxib or diallyl trisulfide topical emulgels, alone or in combination, reduce pruritus and inflammatory cascades in a BALB/c mouse model of imiquimod-induced psoriasis

Kamel, M. M., Zaki, H. F., Saleh, R. A., Henry, S. R., Ibrahim, M. K., Bakr, M. M., Abouhussein, D. M. N., & Rabie, M. A. (2026) · Pharmacia · doi:10.3897/pharmacia.73.e205623

Metabolic control of NETosis: dunnione suppresses inflammatory responses through NQO1–dependent redox modulation

Zhu, M., Lee, S.-H., Oh, G.-S., Kim, J.-S., Seo, J. H., & So, H.-S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1973758

BindingDB Entry 50022873: Discovery of Novel N-Sulfonamide-tetrahydroquinolines as Potent Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists for the Treatment of Psoriasis.

BindingDB (2026) · UC San Diego · doi:10.7270/q2kk9hnw

Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress

Baek, J. O., Byamba, D., Wu, W. H., Kim, T., & Lee, M. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-012-1272-y · Cited by 63 · see citing works

Pioglitazone attenuate level of myeloperoxidases and nitic oxide in psoriatic lesion: a proof-of-concept study in a imiquimod induced psoriasis model in rat

Chatterjee, O., & Sur, D. (2024) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2023-0254 · Cited by 5 · see citing works

Oral Administration of Olive Oil may Exacerbate Imiquimod‐Induced Skin Inflammation in Mice

Romana‐Souza, B., Donato‐Trancoso, A., & Monte‐Alto‐Costa, A. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.610.2

Inhibition of psoriasis-like inflammation in mice by sesamol

Xue, C., Xue-bo, L., & Yu-xuan, W. (2023) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.13652/j.spjx.1003.5788.2023.80244

Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice

Horváth, S., Komlódi, R., Perkecz, A., Pintér, E., Gyulai, R., & Kemény, Á. (2019) · Scientific Reports · doi:10.1038/s41598-019-39903-x · Cited by 71 · see citing works